Parvovirus B19 in Adolescents and Adults: A Case Series of Clinical Mimicry
DOI:
https://doi.org/10.20344/amp.23424Keywords:
Adolescent, Adult, Exanthema, Parvoviridae Infections, Parvovirus B19, HumanAbstract
Parvovirus B19 (PvB19), the etiological agent of erythema infectiosum, can manifest in diverse clinical forms. This study underscores the virus’s capacity to mimic other diseases, as illustrated by the diagnostic challenges encountered across five cases. The first three cases correspond to an overlap of papulo-purpuric gloves and socks syndrome with petechial exanthema with periflexural and periorificial distribution, the first initially diagnosed as a drug eruption, the second as scarlet fever, and the third as autoimmune thrombocytopenia. The remaining two cases correspond to leukocytoclastic vasculitis that, only after thorough investigation, were associated with Parvovirus B19 infection. This case series emphasizes the need for healthcare professionals to be alert to this important imitator and be mindful of this differential diagnosis when approaching exanthemas and vasculitis.
Downloads
References
Mancini AJ, Shani-Adir A, Sidbury R. Other viral diseases. In: Bolognia JL, Schaffer JV, Cerroni L, editors. Dermatology. Amsterdam: Elsevier; 2024. p.1437-60.
Rubin R. What to know about the recent rise in parvovirus b19 infections. JAMA. 2024;332:1226. DOI: https://doi.org/10.1001/jama.2024.19694
Smith PT, Landry ML, Carey H, Krasnoff J, Cooney E. Papular-purpuric gloves and socks syndrome associated with acute parvovirus B19 infection: case report and review. Clin Infect Dis. 1998;27:164-8. DOI: https://doi.org/10.1086/514629
Bloise S, Cocchi E, Mambelli L, Radice C, Marchetti F. Parvovirus B19 infection in children: a comprehensive review of clinical manifestations and management. Ital J Pediatr. 2024;50:261. DOI: https://doi.org/10.1186/s13052-024-01831-6
Russcher A, van Boven M, Benincà E, Verweik EJ, Molenaar de Backer MW, Zaaijer HL, et al. Changing epidemiology of parvovirus B19 in the Netherlands since 1990, including its re-emergence after the COVID-19 pandemic. Sci Rep. 2024;14:9630. DOI: https://doi.org/10.1038/s41598-024-59582-7
Anderer S. Uptick in parvovirus B19. JAMA. 2024;332:1043. DOI: https://doi.org/10.1001/jama.2024.17604
Marano G, Vaglio S, Pupella S, Facco G, Calizzani G, Candura F, et al. Human parvovirus b19 and blood product safety: a tale of twenty years of improvements. Blood Transfus. 2015;13:184-96.
Suzuki M, Watari T. Parvovirus B19 infection: a vasculitis masquerade in an elderly patient. Am J Case Rep. 2023;24:e939696. DOI: https://doi.org/10.12659/AJCR.939696
Karadağ AS, Chen W. Great imitators in dermatology: part I. Clin Dermatol. 2019;37:173-4. DOI: https://doi.org/10.1016/j.clindermatol.2019.04.001
Heegaard ED, Brown KE. Human parvovirus B19. Clin Microbiol Rev. 2002;15:485-505. DOI: https://doi.org/10.1128/CMR.15.3.485-505.2002
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Acta Médica Portuguesa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
